X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/03/07/2621712/0/en/AB2-Bio-Completes-Enrolment-in-Pivotal-Phase-3-Trial-of-Tadekinig-alfa-to-Treat-Primary-Monogenic-IL-18-Driven-HLH.html